ReviewJournal of industrial microbiology & biotechnology2019
Bioactive molecules from Nocardia: diversity, bioactivities and biosynthesis.
Review in Journal of industrial microbiology & biotechnology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed.
- Characterization of a Boron-TolerantMicroorganisms · 2026Article
- Genetic Diversity ofAnimals : an open access journal from MDPI · 2025Article
- Structural Basis for 3-Amino-3-carboxypropyl Transfer in Nocardicin Biosynthesis.Journal of the American Chemical Society · 2025Article
- Article
- Metabarcoding expands knowledge on diversity and ecology of rare actinobacteria in the Brazilian Cerrado.Folia microbiologica · 2025Article
- The genus Nocardia as a source of new antimicrobials.npj antimicrobials and resistance · 2025Review
- Influence of rubber particle inputs on nitrogen removal efficiency of bioretention systems.Water science and technology : a journal of the International Association on Water Pollution Research · 2024Article
- Search for natural products from actinomycetes of the genus Nocardia.Journal of natural medicines · 2024Review
- Analysis of three cases with false positive PCR results of non tuberculosis mycobacterium.Respiratory medicine case reports · 2024Article
- Bioinformatics-guided discovery of biaryl-linked lasso peptides.Chemical science · 2023Article
- Effect of β - hydroxy - γ -aminophosphonate (β - HPC) on the hydrolytic activity ofFrontiers in microbiology · 2023Article
- iChip-Inspired Isolation, Bioactivities and Dereplication ofMicroorganisms · 2022Article
- Metabolic engineering ofEngineering microbiology · 2022Review
- Genome insights into the pharmaceutical and plant growth promoting features of the novel species Nocardia alni sp. nov.BMC genomics · 2022Article
- Two chronically misdiagnosed patients infected withFrontiers in cellular and infection microbiology · 2022Article
- Targeted 16S rRNA gene and ITS2 amplicon sequencing of leaf and spike tissues of Piper longum identifies new candidates for bioprospecting of bioactive compounds.Archives of microbiology · 2021Article
- Whole genome sequencing reveals the genomic diversity, taxonomic classification, and evolutionary relationships of the genus Nocardia.PLoS neglected tropical diseases · 2021Article
- Nocathioamides, Uncovered by a Tunable Metabologenomic Approach, Define a Novel Class of Chimeric Lanthipeptides.Angewandte Chemie (International ed. in English) · 2021Article
- Nargenicin A1 attenuates lipopolysaccharide-induced inflammatory and oxidative response by blocking the NF-κB signaling pathway.EXCLI journal · 2021Article
- A novel LysR-type regulator negatively affects biosynthesis of the immunosuppressant brasilicardin.Engineering in life sciences · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Nocardia spp. are catalase positive, aerobic, and non-motile Gram-positive filamentous bacteria. Many Nocarida spp. have been reported as unusual causes of diverse clinical diseases in both humans and animals. Therefore, they have been studied for a long time, primarily focusing on strain characterization, taxonomic classification of new isolates, and host pathophysiology. Currently, there are emerging interests in isolating bioactive molecules from diverse actinobacteria including Nocardia spp. and studying their biosynthetic mechanisms. In addition, these species possess significant metabolic capacity, which has been utilized for generating diverse functionalized bioactive molecules by whole cell biotransformation. This review summarizes the structural diversity and biological activities of compounds biosynthesized or biotransformed by Nocardia spp. Furthermore, the recent advances on biosynthetic mechanisms and genetic engineering approaches for enhanced production or structural/functional modification are presented.
Indexed as
Identifiers
30659436What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.